Table 3

Logistic regression model of medication adherence (PDC ≥80%) at 6 months following initiation of SPAA or CCB+statin

95% Confidence Limits

Odds Ratio

Lower

Upper

Chi-Square

p-value


Drug Group: SPAA vs. CCB+Statin

4.70

4.22

5.23

793.06

<.001

Gender: Female vs. Male

1.21

1.13

1.30

30.59

<.001

Pre-index Comorbidity of:

Diabetes Mellitus

1.00

0.92

1.07

0.02

0.891

Dyslipidemia

1.22

1.14

1.32

27.80

<.001

Obesity

0.84

0.72

0.98

5.15

0.023

Peripheral Vascular Disease

0.75

0.59

0.94

6.26

0.012

Chronic Obstructive Pulmonary Disease

0.82

0.67

0.99

4.17

0.041

Number of Pre-Index Other Antihypertensive Classes

1.12

1.06

1.18

18.93

<.001


Chapman et al. BMC Cardiovascular Disorders 2010 10:29   doi:10.1186/1471-2261-10-29

Open Data